Browsing by Author Zalcberg, John

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 21 to 32 of 32 < previous 
Issue DateTitleAuthor(s)Citation
2009Prospective Cost-Effectiveness Analysis of Cetuximab in Metastatic Colorectal Cancer: Evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 TrialSimes, Robert John; Tebbutt, Niall; Zalcberg, John; Au, Heather-Jane; Australasian Gastrointestinal Interest, Group; Colwell, Bruce; Evans, William K.; Findlay, Brian; Gibbs, Peter; Isogai, Pierre K.; Jonker, Derek J.; Karapetis, Christos; Links, Matthew; Mittman, Nicole; Moore, Malcolm; O'Callaghan, Chris; Siddiqui, Jehan; Tu, D.; Working Group on Economic Analysis of the National Cancer Institute of Canada, Clinical Trials Group; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreProspective Cost-Effectiveness Analysis of Cetuximab in Metastatic Colorectal Cancer: Evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 Trial, Journal of the National Cancer Institute, vol.101, 17, 2009,pp 1182-1192
2014Quality of life in patients with K-RAS wild-type colorectal cancer: the CO.20 phase 3 randomized trialEl-Tahche, Fabyolla; Shannon, Jenny; Alcindor, Thierry; Au, Heather-Jane; Easaw, Jay C; et al, Various; Jeffery, Mark; Jonker, Derek J.; Kotb, Rami; Moore, Malcolm; Ng, Siobhan; Ringash, Jolie; Sabesan, Sabe; Salim, Muhammad; Shapiro, Jeremy; Siu, Lillian L; Strickland, A. H.; Zalcberg, John; Central Clinical School: Medicine; Nepean Clinical School: MedicineQuality of life in patients with K-RAS wild-type colorectal cancer: the CO.20 phase 3 randomized trial, Cancer, vol.120, 2, 2014,pp 181-189
2010Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trialCummins, Michelle; Gebski, Val; Sourjina, Tatiana; Stockler, Martin; Ganju, Vinod; Gibbs, David; Strickland, A. H.; Tebbutt, Niall C; van Hazel, Guy; Zalcberg, John; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreRandomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial, British Journal of Cancer, vol.102, 3,pp 475-481
2012Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04Solomon, Michael; Ackland, Stephen; Burmeister, Bryan H.; Fisher, Richard; Goldstein, D; Hartopeanu, Chris; Joseph, David; Leong, T.; Mackay, John; McClure, Bev; McKendrick, J; McLachlan, Sue Anne; Ngan, S. Y.; Schache, David; Zalcberg, John; Central Clinical School: SurgeryRandomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04, Journal of Clinical Oncology, vol.30, 31, 2012,pp 3827-3833
2016Regorafenib for the treatment of advanced gastric cancer (INTEGRATE): A multinational placebo-controlled phase II TrialMartin, Andrew; Pavlakis, Nick; Simes, Robert John; Sjoquist, Katrin; Tsobanis, Eric; Wong, Ka (Mark); Yip, Sonia; Alcindor, Thierry; bang, Yungjue; Burnell, Margot J; Cho, Jaeyong; Goldstein, David; Kang, Yoon-Koo; Kim, Jinwon; Lee, Jeeyun; Lipton, Lara; O'Callaghan, Chris; Rha, Sunyoung; Strickland, A. H.; Tebbutt, Niall; Zalcberg, John; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); NH&MRC Clinical Trials CentreRegorafenib for the treatment of advanced gastric cancer (INTEGRATE): A multinational placebo-controlled phase II Trial, Journal of Clinical Oncology, vol.34, 23, 2016,pp 2728-2735
2014Regorafenib in gastrointestinal stromal tumors: clinical evidence and place in therapyFerraro, Danielle Angela; Zalcberg, John; School of Public Health: NH&MRC Clinical Trials CentreRegorafenib in gastrointestinal stromal tumors: clinical evidence and place in therapy, Therapeutic Advances in Medical Oncology, vol.6, 5, 2014,pp 222-228
2014The relationship between rash, tumour KRAS mutation status and clinical and quality of life outcomes in patients with advanced colorectal cancer treated with cetuximab in the NCIC CTG/AGITG CO.17Simes, Robert John; Sommeijer, Dirkje; Jonker, Derek J.; Karapetis, Christos; O’CALLAGHAN, Chris; Price, Timothy; Tebbutt, Niall; Tu, Dongsheng; Yip, Desmond; Zalcberg, John; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreThe relationship between rash, tumour KRAS mutation status and clinical and quality of life outcomes in patients with advanced colorectal cancer treated with cetuximab in the NCIC CTG/AGITG CO.17, Acta Oncologica, vol.53, 7, 2014,pp 877-884
2006Relationship of Hepatic Functional Imaging to Irinotecan Pharmacokinetics and Genetic Parameters of Drug Elimination.Clarke, Stephen; Zalcberg, John; Di Iulio, Juliana; Ellis, Andrew; et, al; Gurtler, Volker; Hicks, Rod J.; Michael, Michael; Milner, Alvin D.; Mitchell, Paul L.; Scott, Andrew; Thompson, Mick; Concord Clinical School: ANZAC Research Institute; School of Public Health: NH&MRC Clinical Trials CentreRelationship of Hepatic Functional Imaging to Irinotecan Pharmacokinetics and Genetic Parameters of Drug Elimination., JOURNAL OF CLINICAL ONCOLOGY 2005, vol.24,(26),2006,pp 4228-4235
2011Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysisBoland, Amy L.; Brown, Christopher; Clarke, Stephen; Gebski, Val; Simes, Robert John; Yip, Sonia; Buck, M; Goldstein, David; Jeffrey, G. Mark; Lowenthal, Raymond M.; Ransom, David T.; Tebbutt, Niall C; van Hazel, Guy; Zalcberg, John; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Northern Clinical School: Kolling Institute; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreSingle-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis, European Journal of Cancer, vol.47, 12, 2011,pp 1826-1836
2011Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysisGebski, Val; Simes, Robert John; Sjoquist, Katrin; Barbour, Andrew; Burmeister, Bryan H.; Smithers, Bernard Mark; Zalcberg, John; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreSurvival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis, Lancet Oncology, vol.12, 7, 2011,pp 681-692
2007Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysisFoo, Kerwyn; Gebski, Val; Simes, Robert John; Burmeister, Bryan H.; Smithers, Bernard Mark; Zalcberg, John; Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreSurvival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis, Lancet Oncology, vol.8,(3),2007,pp 226-234
2017TOPGEAR: A Randomized, Phase III Trial of Perioperative ECF Chemotherapy with or Without Preoperative Chemoradiation for Resectable Gastric Cancer: Interim Results from an International, Intergroup Trial of the AGITG, TROG, EORTC and CCTGGebski, Val; Miller, Danielle; O'Connell, Rachel; Simes, Robert John; Verghis, Jaclyn; Boussioutas, A; et al, Various; Findlay, M; Haustermans, Karin; Kron, Thomas; Leong, T; Michael, Michael; Smithers, B. Mark; Willis, David; Zalcberg, John; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreTOPGEAR: A Randomized, Phase III Trial of Perioperative ECF Chemotherapy with or Without Preoperative Chemoradiation for Resectable Gastric Cancer: Interim Results from an International, Intergroup Trial of the AGITG, TROG, EORTC and CCTG, Annals of Surgical Oncology, vol.24, 8, 2017,pp 2252-2258